Finance

Lists
Why is 31R up 9,52%?
Dive Deeper
31R:FRA
Revive Therapeutics Ltd
€0,012
+9,52%
(+0,0010) 1D
7 ຕ.ລ., 8 ໂມງ 4 ນາທີ 07 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
€0,01
High
€0,01
Low
€0,01
Mkt. cap
10,46 ລ້ານ
Avg. vol.
2,94 ພັນ
Volume
0,00
52-wk high
€0,06
52-wk low
€0,00
Open
€0,01
High
€0,01
Low
€0,01
Mkt. cap
10,46 ລ້ານ
Avg. vol.
2,94 ພັນ
Volume
0,00
52-wk high
€0,06
52-wk low
€0,00
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
Headquartersໂຕຣອນໂຕ, ອອນທາຣິໂອ, ແຄນາດາ
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 ພັນ
200,14 ພັນ
283,25 ພັນ
242,05 ພັນ
Operating expense
336,39 ພັນ
220,13 ພັນ
283,30 ພັນ
463,87 ພັນ
Total operating expenses
336,39 ພັນ
220,13 ພັນ
283,30 ພັນ
463,87 ພັນ
Operating income
-336,39 ພັນ
-220,13 ພັນ
-283,30 ພັນ
-463,87 ພັນ
Other non operating income
73,85 ພັນ
-
-
-
EBT including unusual items
-9,60 ລ້ານ
-281,75 ພັນ
-238,72 ພັນ
-506,50 ພັນ
EBT excluding unusual items
-143,94 ພັນ
-281,75 ພັນ
-234,70 ພັນ
-506,50 ພັນ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 ລ້ານ
-281,75 ພັນ
-238,72 ພັນ
-506,50 ພັນ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 ພັນ
-220,08 ພັນ
-283,25 ພັນ
-463,82 ພັນ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google